tiprankstipranks

Robert Hariri Insider Profile

4 Followers
Robert Hariri, Director at MedAvail Holdings, holds 42.25K shares in BioVie (Ticker: BIVI), holds 28.57M shares in Celularity (Ticker: CELU), holds 14.52K shares in CryoPort (Ticker: CYRX).
tipranks
Robert Hariri

Robert Hariri
MedAvail Holdings (MDVL)
Director

Ranked #95,905 out of 99,644 Corporate Insiders

Profitable Transactions

24%
4 out of 17 Profitable Transactions

Average Return

-29.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
91.27%
4.16%
3.43%
1.14%
A breakdown of Robert Hariri's holdings

Insider Roles

Celularity
(CELU)
CEO, Director
MedAvail Holdings
(MDVL)
Director
CryoPort
(CYRX)
Director
BioVie
(BIVI)
Director
Roles that Robert Hariri holds in companies

Most Profitable Insider Trade

Stock:
CryoPort
(CYRX)
Rating:Informative Buy
Date:Jul 31, 2020 - Jul 31, 2021
Return:+86.20%
The most profitable trade made by Robert Hariri

Robert Hariri's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MedAvail Holdings
Apr 06, 2020
Director
Uninformative Buy
$268.57K
CryoPort
Sep 12, 2023
Director
Informative Sell
20.40K
$221.08K
Celularity
Oct 10, 2023
CEO, Director
Informative Buy
2.85M
$5.89M
BioVie
Dec 06, 2023
Director
Uninformative Buy
$73.52K
WGBS
WaferGen Bio systems
Sep 20, 2011
Uninformative Buy
$1.10M
List of latest transactions for each holding click on a transaction to see Robert Hariri's performance on stock

Robert Hariri insider profile FAQ

What is the percentage of profitable transactions made by Robert Hariri?
The percentage of profitable transactions made by Robert Hariri is 24%.
    What is the average return per transaction made by Robert Hariri?
    The average return per transaction made by Robert Hariri is -29.90%.
      What stocks does Robert Hariri hold?
      Robert Hariri holds: MDVL, CYRX, CELU, BIVI, WGBS stocks.
        What was Robert Hariri’s latest transaction?
        Robert Hariri latest transaction was an Uninformative Buy of ―.
          What was Robert Hariri's most profitable transaction?
          Robert Hariri’s most profitable transaction was an Informative Buy of CYRX stock on July 31, 2020. The return on the trade was 86.20%.
            What is Robert Hariri's role in MedAvail Holdings?
            Robert Hariri's role in MedAvail Holdings is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.